出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2024年4月
Beta-glucan Market – Global Forecast To 2029
β-グルカン市場 : カテゴリ (水溶性、不溶性)、原料 (穀物＆穀物、キノコ、酵母、海藻)、用途 (食品＆飲料、栄養補助食品、パーソナルケア、化粧品、医薬品、動物飼料)、種類と地域別 – 2029年までの世界予測
Beta-Glucan Market by Category (Soluble, Insoluble), Source (Cereal & Grains, Mushroom, Yeast, Seaweed), Application (Food & Beverage, Dietary Supplement, Personal Care, Cosmetics, Pharmaceutical, Animal Feed), Type and Region – Global Forecast to 2029
| ページ数 | 323 |
| 図表数 | 432 |
| 価格 | |
| シングルユーザライセンス | USD 4,950 |
| マルチユーザライセンス（5名） | USD 6,650 |
| コーポレートライセンス | USD 8,150 |
| エンタープライズサイトライセンス | USD 10,000 |
| 種別 | 英文調査報告書 |
Report Overview
The beta-glucan market is on a trajectory to witness substantial growth, with its value expected to soar from USD 542 million in 2024 to an estimated USD 800 million by 2029.
β-グルカン市場は大幅な成長軌道に乗っており、その価値は2024年の5億4,200万米ドルから2029年までに推定8億米ドルに急上昇すると予想されています。
This expansion represents a healthy CAGR of 8.1% throughout the projected period. Several key factors are fueling this upward trend, there is a growing consumer preference for natural and clean-label additives in food and beverages. As people become more health-conscious, there’s an increasing demand for products that are perceived as natural and wholesome. Beta-glucan, which is a soluble fiber found in various sources such as oats, barley, and mushrooms, fits into this trend perfectly. It not only acts as a natural additive but also offers functional benefits, making it attractive for use in a wide range of food and beverage products.
There is a rising awareness and adoption of high-fiber diets among consumers. High-fiber diets are known to offer a myriad of health benefits, including improved digestive health, better weight management, and reduced risk of chronic diseases like heart disease and diabetes. Beta-glucan, being a soluble fiber, has been shown to help lower cholesterol levels and improve heart health, making it a sought-after ingredient for health-conscious consumers.
“The segment cereals & grains is expected to account for the largest share in 2024.”
Cereals and grains are recognized for their elevated levels of beta-glucan compared to many other food types. Notably, oats and barley are particularly rich in beta-glucan, with oats standing out as one of the most abundant dietary sources. The beta-glucans found in cereals and grains are usually of the mixed-linkage variety, which has demonstrated beneficial health effects, including immune-modulating and cholesterol-reducing properties. Due to their high beta-glucan content, cereals and grains are sought-after sources for obtaining this advantageous compound. Beneo’s recent launch of Orafti β-Fit in July 2023, a barley beta-glucans ingredient, exemplifies the industry’s response to increasing awareness of beta-glucans and their health benefits. This innovative product not only offers significant health advantages like improving heart health and blood sugar management but also provides food manufacturers with an appealing ingredient for creating nutritional products. Beneo’s introduction of Orafti β-Fit is part of a broader trend where companies are actively meeting the rising demand for beta-glucans by developing and launching new products. Such initiatives demonstrate the industry’s commitment to connecting nutrition and health, addressing consumer needs for functional and health-promoting food options.
“The soluble beta-glucan segment is projected to dominate the market in the category segment during the forecast period.”
Soluble beta-glucan, a form of soluble fiber present in foods like oats, barley, and mushrooms, offers a range of health advantages. These include lowering cholesterol, enhancing immune response, and potentially decreasing the likelihood of certain cancers.
The surging interest in soluble beta-glucan is fueled by an expanding body of research highlighting its health-promoting properties. A 2020 study featured in Nutrients found that incorporating beta-glucan from sources like oats and barley into one’s diet can lead to reductions in both total and LDL cholesterol, key indicators of heart disease risk. Furthermore, the study suggested additional cardiovascular benefits associated with beta-glucan, such as diminishing inflammation and boosting endothelial function..
“Changes in dietary choices have positioned North America as a dominating region in the beta-glucan market.”
The North American beta-glucan market is experiencing robust growth, driven by its multifaceted applications across various products and the associated health benefits. Leading market players, including Cargill (US), Millipore Sigma (Germany), and Lesaffre (France), are leveraging technological innovations to expand beta-glucan’s use in the food and beverage industry, serving as thickening agents, fat substitutes, dietary fiber, and hypocholesterolemic agents. These advancements are anticipated to fuel market growth in the region.
In the US, consumer trends are shifting towards calorie-conscious choices, leading to a preference for low-calorie and low-fat food options. This change is not only influenced by a general health consciousness but also by the rising prevalence of obesity and cardiovascular diseases. Data from the CDC and the National Health and Nutrition Examination Survey (2021-2022) indicates that the obesity rate among adults in the US has surged to 42.4% between 2020 and 2021.
Furthermore, the escalating number of diabetes cases is reshaping dietary habits, with consumers increasingly seeking natural and low-calorie ingredients to manage their health. Given the significant diabetes prevalence in the US, where 38.4 million people, or 11.6% of the population, have diabetes and an additional 97.6 million adults have prediabetes, there is a growing demand for functional food ingredients like beta-glucan. Beta-glucan’s potential benefits in managing blood sugar levels make it a particularly attractive option for diabetes patients and those at risk of developing the condition. As such, the changing dietary habits driven by the diabetes epidemic are expected to further propel the growth of the beta-glucan market in North America.
The break-up of the profile of primary participants in the beta-glucan market:
- By Company Type: Tier 1 – 25%, Tier 2 – 45%, and Tier 3 – 30%
- By Designation: CXO’s – 20%, Managers – 50%, Executives- 30%
- By Region: North America – 25%, Europe – 20%, Asia Pacific – 30%, South America – 15% and Rest of the World –10%
Prominent companies Tate & Lyle PLC (London), Kerry Group PLC (Ireland), DSM Firmenich (Switzerland), Merck (US), Kemin Industries (US), Alltech (US), AngelYeast Co., Ltd (China), Lallemand Inc. (Canada), Leiber (Germany), Lesaffre (France) Associated British Foods Plc (UK), Biorigin (Brazil), Ceapro Inc. (Canada), Specialty Biotech Co., Ltd. (US), Alltech (US), Garuda International Inc. (US), and Leiber (Germany).
Other players include VW-Ingredients (Netherlands), Super Beta Glucan(US), GlycaNova AS (Norway), NutriScience Innovations, LLC (US), Algalíf Iceland hf. (Iceland), ABAC R&D (Switzerland), Natural Biologics (New Zealand), BENEO (Germany), L&P Food Ingredient Co., Ltd. (China), Beta Bio Technology sp. z o. o (Poland).
Research Coverage:
This research report categorizes the beta-glucan market by Source (Grains & Cereals, Mushrooms, Yeast, and Seaweed), Category (Soluble and Insoluble), Application (Food & Beverage, Personal Care, Pharmaceutical, Dietary Supplement and Animal Feed), Type ( {1,3} beta-glucan, {1,4} beta-glucan, {1,6} beta-glucan) and region (North America, Europe, Asia Pacific, South America, and Rest of the World). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the beta-glucan market. A detailed analysis of the key industry players has been done to provide insights into their business overview, key strategies, contracts, partnerships & agreements, new product launches, mergers & acquisitions, and recent developments associated with the beta-glucan market. Competitive analysis of upcoming startups in the de-oiled lecithin market ecosystem is covered in this report.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall beta-glucan market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
• Analysis of key drivers (Increase in application of beta glucan in different industries), restraints (Inconsistency in regulatory norms governing beta-glucan), opportunities (Untapped beta-glucan applications), and challenges (Lack of consumer awareness) influencing the growth of the beta-glucan market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the beta-glucan market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the beta-glucan market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the beta-glucan market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Tate & Lyle PLC (England), Kerry Group PLC (Ireland), dsm-Firmenich (Switzerland), Merck (Germany), among others in the beta-glucan market strategies. The report also helps stakeholders understand the beta-glucan market and provides them information on key market drivers, restraints, challenges, and opportunities.
Table of Contents
1 INTRODUCTION 44
1.1 STUDY OBJECTIVES 44
1.2 MARKET DEFINITION 44
1.3 STUDY SCOPE 45
1.3.1 MARKET SEGMENTATION 45
1.3.2 INCLUSIONS AND EXCLUSIONS 45
1.3.3 REGIONS COVERED 46
1.3.4 YEARS CONSIDERED 47
1.4 CURRENCY CONSIDERED 47
TABLE 1 USD EXCHANGE RATES, 2019–2023 48
1.5 UNIT CONSIDERED 48
1.6 STAKEHOLDERS 48
1.7 SUMMARY OF CHANGES 49
1.7.1 IMPACT OF RECESSION 49
2 RESEARCH METHODOLOGY 50
2.1 RESEARCH DATA 50
FIGURE 1 BETA-GLUCAN MARKET: RESEARCH DESIGN 50
2.1.1 SECONDARY DATA 51
2.1.1.1 Key data from secondary sources 51
2.1.2 PRIMARY DATA 51
2.1.2.1 Key data from primary sources 52
2.1.2.2 Breakdown of primary profiles 53
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 53
2.1.2.3 Key insights from industry experts 53
2.2 MARKET SIZE ESTIMATION 54
2.2.1 TOP-DOWN APPROACH 54
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 55
2.2.2 SUPPLY-SIDE ANALYSIS 55
FIGURE 4 BETA-GLUCAN MARKET SIZE CALCULATION: SUPPLY SIDE 56
2.2.3 BOTTOM-UP APPROACH (DEMAND SIDE) 56
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 57
2.3 DATA TRIANGULATION AND MARKET BREAKUP 58
FIGURE 6 DATA TRIANGULATION 58
2.4 RESEARCH ASSUMPTIONS 59
2.5 LIMITATIONS AND RISK ASSESSMENT 60
2.6 RECESSION IMPACT ANALYSIS 60
2.6.1 MACRO-INDICATORS OF RECESSION 61
FIGURE 7 RECESSION INDICATORS 61
FIGURE 8 GLOBAL INFLATION RATE, 2011–2022 62
FIGURE 9 GLOBAL GDP, 2011–2022 (USD TRILLION) 63
FIGURE 10 RECESSION INDICATORS AND THEIR IMPACT ON BETA-GLUCAN MARKET 64
FIGURE 11 GLOBAL BETA-GLUCAN MARKET: EARLIER FORECAST VS. RECESSION FORECAST 64
3 EXECUTIVE SUMMARY 65
TABLE 2 BETA-GLUCAN MARKET SHARE SNAPSHOT, 2024 VS. 2029 (USD MILLION) 66
FIGURE 12 BETA-GLUCAN MARKET, BY SOURCE, 2024 VS. 2029 (USD MILLION) 67
FIGURE 13 BETA-GLUCAN MARKET, BY CATEGORY, 2024 VS. 2029 (USD MILLION) 67
FIGURE 14 BETA-GLUCAN MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 68
FIGURE 15 BETA-GLUCAN MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 68
FIGURE 16 BETA-GLUCAN MARKET SHARE AND GROWTH RATE, BY REGION, 2024 (BY VALUE) 69
4 PREMIUM INSIGHTS 70
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN BETA-GLUCAN MARKET 70
FIGURE 17 CONSUMER PREFERENCES FOR HEALTHY AND NUTRITIONAL PROTEIN TO DRIVE BETA-GLUCAN MARKET 70
4.2 ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY AND COUNTRY 71
FIGURE 18 CHINA AND SOLUBLE SEGMENT TO ACCOUNT FOR SIGNIFICANT SHARES IN 2024 71
4.3 BETA-GLUCAN MARKET, BY TYPE 71
FIGURE 19 (1,3 BETA-GLUCAN) SEGMENT TO ACCOUNT FOR LARGEST MARKET DURING FORECAST PERIOD 71
4.4 BETA-GLUCAN MARKET, BY SOURCE 72
FIGURE 20 CEREALS & GRAINS SEGMENT TO LARGEST MARKET DURING FORECAST PERIOD 72
4.5 BETA-GLUCAN MARKET, BY CATEGORY 72
FIGURE 21 SOLUBLE SEGMENT TO ACCOUNT FOR LARGER MARKET DURING FORECAST PERIOD 72
4.6 BETA-GLUCAN MARKET, BY APPLICATION 73
FIGURE 22 FOOD & BEVERAGES SEGMENT TO ACCOUNT FOR LARGEST MARKET DURING FORECAST PERIOD 73
4.7 BETA-GLUCAN MARKET, BY CATEGORY AND REGION 74
FIGURE 23 SOLUBLE SEGMENT TO LEAD ACROSS ALL REGIONAL MARKETS DURING FORECAST PERIOD 74
4.8 BETA-GLUCAN MARKET: REGIONAL SNAPSHOT 75
FIGURE 24 US TO DOMINATE BETA-GLUCAN MARKET IN 2024 75
5 MARKET OVERVIEW 76
5.1 INTRODUCTION 76
5.2 MACROECONOMIC INDICATORS 76
5.2.1 RISING GLOBAL DOMESTIC PRODUCT AND POPULATION GROWTH TO DRIVE APPETITE FOR BETA-GLUCAN 76
FIGURE 25 GLOBAL POPULATION GROWTH, 1950–2050 (BILLION) 77
FIGURE 26 GDP GROWTH, 2016–2022 (TRILLION) 77
5.2.2 RISING HEALTH CONCERNS AND GROWTH IN DISEASES 77
FIGURE 27 PERCENTAGE POPULATION OF CANCER PATIENTS, BY REGION, 2022 78
5.2.3 INCREASE IN CONSUMPTION OF DIETARY FIBERS 78
5.3 MARKET DYNAMICS 79
FIGURE 28 BETA-GLUCAN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 79
5.3.1 DRIVERS 79
5.3.1.1 Growth in health consciousness and increasing health expenditure 79
FIGURE 29 GLOBAL OECD HEALTH SPENDING AS SHARE OF GLOBAL DOMESTIC PRODUCT, 2017–2021 80
5.3.1.2 Increasing research and application of beta-glucan in fast-moving industries 80
5.3.2 RESTRAINTS 81
5.3.2.1 Inconsistency in regulatory norms governing beta-glucan 81
5.3.2.2 Price volatility of raw materials 81
5.3.3 OPPORTUNITIES 82
5.3.3.1 Growing demand for natural and plant-based ingredients 82
5.3.3.2 Demand for personalized nutrition and tailored beta-glucan products 82
5.3.3.3 Untapped beta-glucan applications 83
5.3.4 CHALLENGES 83
5.3.4.1 Lack of consumer awareness regarding benefits of beta-glucan 83
5.3.4.2 High research and development costs 84
6 INDUSTRY TRENDS 85
6.1 INTRODUCTION 85
6.2 SUPPLY CHAIN ANALYSIS 85
FIGURE 30 BETA-GLUCAN MARKET: SUPPLY CHAIN ANALYSIS 85
6.3 VALUE CHAIN ANALYSIS 86
FIGURE 31 BETA-GLUCAN MARKET: VALUE CHAIN ANALYSIS 86
6.3.1 RESEARCH & DEVELOPMENT 87
6.3.2 RAW MATERIAL SOURCING 87
6.3.3 PRODUCTION 87
6.3.4 DISTRIBUTION 87
6.3.5 END USERS 87
6.4 TRADE ANALYSIS 88
6.4.1 IMPORT SCENARIO OF YEAST 88
FIGURE 32 HS CODE 2102: IMPORT VALUE OF YEAST, BY KEY COUNTRY, 2019–2023 88
TABLE 3 HS CODE 2102: IMPORT SCENARIO OF YEAST, BY COUNTRY, 2022 (USD) 89
6.4.2 EXPORT SCENARIO OF YEAST 89
FIGURE 33 HS CODE 2102: EXPORT VALUE OF YEAST, BY KEY COUNTRY, 2019–2023 89
TABLE 4 HS CODE 2102: EXPORT SCENARIO OF YEAST, BY COUNTRY, 2022 (USD) 90
6.4.3 IMPORT SCENARIO OF MUSHROOMS 90
FIGURE 34 HS CODE 2003: IMPORT VALUE OF MUSHROOMS, BY KEY COUNTRY, 2019–2023 90
TABLE 5 HS CODE 2003: IMPORT SCENARIO OF MUSHROOMS, BY COUNTRY, 2022 (USD) 91
6.4.4 EXPORT SCENARIO OF MUSHROOMS 91
FIGURE 35 HS CODE 2003: EXPORT VALUE OF MUSHROOMS, BY KEY COUNTRY, 2019–2023 91
TABLE 6 HS CODE 2003: EXPORT SCENARIO OF MUSHROOMS, BY COUNTRY, 2022 (USD) 92
6.4.5 IMPORT SCENARIO OF OATS 92
FIGURE 36 HS CODE 1004: IMPORT VALUE OF OATS, BY KEY COUNTRY, 2019–2023 92
TABLE 7 HS CODE 1004: IMPORT SCENARIO OF OATS, BY COUNTRY, 2022 (USD) 93
6.4.6 EXPORT SCENARIO OF OATS 93
FIGURE 37 HS CODE 1004: EXPORT VALUE OF OATS, BY KEY COUNTRY, 2019–2023 93
TABLE 8 HS CODE 1004: EXPORT SCENARIO OF OATS, BY COUNTRY, 2022 (USD) 94
6.4.7 IMPORT SCENARIO OF BARLEY 94
FIGURE 38 HS CODE 1003: IMPORT VALUE OF BARLEY, BY KEY COUNTRY, 2019–2023 94
TABLE 9 HS CODE 1003: IMPORT SCENARIO OF BARLEY, BY COUNTRY, 2022 (USD) 95
6.4.8 EXPORT SCENARIO OF BARLEY 95
FIGURE 39 HS CODE 1003: EXPORT VALUE OF BARLEY, BY KEY COUNTRY, 2019–2023 95
TABLE 10 HS CODE 1003: EXPORT SCENARIO OF BARLEY, BY COUNTRY, 2022 (USD) 96
6.5 TECHNOLOGY ANALYSIS 96
6.5.1 KEY TECHNOLOGIES 96
6.5.1.1 Encapsulation 96
6.5.2 COMPLEMENTARY TECHNOLOGIES 97
6.5.2.1 High-purity yeast beta-glucan technology 97
6.5.3 ADJACENT TECHNOLOGIES 97
6.5.3.1 New avenues for yeast culture and extraction 97
6.6 PRICING ANALYSIS 98
6.6.1 AVERAGE SELLING PRICE TREND, BY REGION 98
TABLE 11 BETA-GLUCAN MARKET: AVERAGE SELLING PRICE TREND, BY REGION, 2023–2029 (USD/TONS) 98
6.6.2 AVERAGE SELLING PRICE TREND, BY SOURCE 98
TABLE 12 BETA-GLUCAN MARKET: AVERAGE SELLING PRICE TREND, BY SOURCE, 2023–2029 (USD/TONS) 98
FIGURE 40 AVERAGE SELLING PRICE TREND, BY SOURCE (USD/TONS) 98
6.7 ECOSYSTEM/MARKET MAP 99
6.7.1 DEMAND SIDE 99
6.7.2 SUPPLY SIDE 99
FIGURE 41 KEY PLAYERS IN BETA-GLUCAN MARKET ECOSYSTEM 100
TABLE 13 BETA-GLUCAN MARKET: ECOSYSTEM 100
6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 102
FIGURE 42 REVENUE SHIFT FOR BETA-GLUCAN MARKET VENDORS 102
6.9 PATENT ANALYSIS 102
TABLE 14 LIST OF MAJOR PATENTS PERTAINING TO BETA-GLUCAN MARKET, 2014–2024 102
FIGURE 43 NUMBER OF PATENTS GRANTED FOR BETA-GLUCAN, 2014–2023 104
FIGURE 44 REGIONAL ANALYSIS OF PATENTS GRANTED FOR BETA-GLUCAN 104
6.10 KEY CONFERENCES AND EVENTS 105
TABLE 15 BETA-GLUCAN MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2024 105
6.11 REGULATORY LANDSCAPE 106
6.11.1 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106
6.11.1.1 North America 106
TABLE 16 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106
6.11.1.2 Europe 107
TABLE 17 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 107
6.11.1.3 Asia Pacific 108
TABLE 18 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 108
6.11.1.4 RoW 108
TABLE 19 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 108
6.11.2 REGULATORY FRAMEWORK 109
6.11.2.1 Introduction 109
6.11.2.2 North America 109
6.11.2.2.1 US Food and Drug Administration (21CFR101.14) 109
6.11.2.2.2 US Food and Drug Administration (21CFR101.81) 109
6.11.2.3 European Food Safety Authority 109
6.11.2.3.1 European Union 110
6.12 PORTER’S FIVE FORCES’ ANALYSIS 110
TABLE 20 PORTER’S FIVE FORCES’ IMPACT ON BETA-GLUCAN MARKET 110
6.12.1 THREAT OF NEW ENTRANTS 110
6.12.2 THREAT OF SUBSTITUTES 111
6.12.3 BARGAINING POWER OF SUPPLIERS 111
6.12.4 BARGAINING POWER OF BUYERS 111
6.12.5 INTENSITY OF COMPETITIVE RIVALRY 111
6.13 KEY STAKEHOLDERS AND BUYING CRITERIA 112
6.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 112
FIGURE 45 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP APPLICATIONS 112
TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP APPLICATIONS 112
6.13.2 BUYING CRITERIA 113
TABLE 22 KEY BUYING CRITERIA FOR TOP APPLICATIONS 113
FIGURE 46 KEY BUYING CRITERIA FOR TOP APPLICATIONS 113
6.14 CASE STUDY ANALYSIS 114
6.14.1 CARGILL INVESTED USD 35 MILLION TO PRODUCE SOLUBLE FIBERS THAT MEET CONSUMER DEMAND FOR HEALTHY PRODUCTS 114
6.14.2 TATE & LYLE ENTERED INTO PARTNERSHIP WITH SOLEVO TO DISTRIBUTE WIDE RANGE OF PRODUCTS AND TAP UNTAPPED OPPORTUNITIES 114
6.15 BETA-GLUCAN PURITY ANALYSIS 115
6.15.1 ACIDIC EXTRACTION 115
6.15.2 ALKALINE EXTRACTION 115
6.15.3 WATER EXTRACTION 115
6.15.4 ENZYMATIC EXTRACTION 115
7 BETA-GLUCAN MARKET, BY EXTRACTION METHOD 116
7.1 INTRODUCTION 116
TABLE 23 BETA-GLUCAN YIELDS AND PRODUCTION TECHNOLOGIES FROM VARIOUS SOURCES 116
7.2 BETA-GLUCAN FROM CEREALS 117
7.3 BETA-GLUCAN FROM YEAST 117
8 BETA-GLUCAN MARKET, BY APPLICATION 118
8.1 INTRODUCTION 119
TABLE 24 APPLICATION OVERVIEW 119
FIGURE 47 BETA-GLUCAN MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 120
TABLE 25 BETA-GLUCAN MARKET: BY APPLICATION, 2019–2023 (USD MILLION) 120
TABLE 26 BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 120
8.2 FOOD & BEVERAGES 121
8.2.1 INCREASING AWARENESS OF HEALTH BENEFITS IN PREVENTING AND MANAGING CHRONIC DISEASES TO DRIVE DEMAND FOR BETA-GLUCAN 121
TABLE 27 FOOD & BEVERAGES: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION) 121
TABLE 28 FOOD & BEVERAGES: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION) 122
8.3 PERSONAL CARE 122
8.3.1 GROWING CONSUMER DEMAND FOR NATURAL AND HEALTHY PRODUCTS AND AWARENESS REGARDING SKIN HEALTH TO PROPEL MARKET 122
TABLE 29 PERSONAL CARE: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION) 123
TABLE 30 PERSONAL CARE: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION) 123
8.3.1.1 By form 123
8.3.1.1.1 Creams 123
8.3.1.1.2 Lotions 123
8.3.1.1.3 Other personal care forms 124
TABLE 31 PERSONAL CARE: BETA-GLUCAN MARKET, BY FORM, 2019–2023 (USD MILLION) 124
TABLE 32 PERSONAL CARE: BETA-GLUCAN MARKET, BY FORM, 2024–2029 (USD MILLION) 124
8.3.1.2 By functionality 124
8.3.1.2.1 Spot reduction 124
8.3.1.2.2 Skin treatment/Wound healing 124
8.3.1.2.3 Skin moisturization & hydration 125
8.3.1.2.4 Anti-irritation/Anti-inflammatory 125
8.3.1.2.5 Collagen stimulation & anti-aging 125
8.3.1.2.6 Other personal care functionalities 125
TABLE 33 PERSONAL CARE: BETA-GLUCAN MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION) 125
TABLE 34 PERSONAL CARE: BETA-GLUCAN MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION) 126
8.4 COSMETICS 126
8.4.1 BETA-GLUCAN TO IMPROVE SPREADABILITY OF FORMULATIONS AND ENHANCE THEIR ADHERENCE TO SKIN 126
TABLE 35 COSMETICS: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION) 126
TABLE 36 COSMETICS: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION) 127
8.4.1.1 By form 127
8.4.1.1.1 Creams 127
8.4.1.1.2 Lotions 127
8.4.1.1.3 Other cosmetics forms 127
TABLE 37 COSMETICS: BETA-GLUCAN MARKET, BY FORM, 2019–2023 (USD MILLION) 128
TABLE 38 COSMETICS: BETA-GLUCAN MARKET, BY FORM, 2024–2029 (USD MILLION) 128
8.4.1.2 By functionality 128
8.4.1.2.1 UV protection 128
8.4.1.2.2 Barrier enhancement 128
8.4.1.2.3 Skin moisturization & hydration 128
8.4.1.2.4 Collagen stimulation & anti-aging 129
8.4.1.2.5 Other cosmetics functionalities 129
TABLE 39 COSMETICS: BETA-GLUCAN MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION) 129
TABLE 40 COSMETICS: BETA-GLUCAN MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION) 129
8.5 PHARMACEUTICALS 130
8.5.1 GOVERNMENT INVESTMENT IN BENEFITS OF BETA-GLUCAN IN PHARMACEUTICAL APPLICATIONS TO SPUR MARKET 130
TABLE 41 PHARMACEUTICALS: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION) 130
TABLE 42 PHARMACEUTICALS: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION) 131
8.6 DIETARY SUPPLEMENTS 131
8.6.1 NEED FOR IMMUNE SYSTEM SUPPORT, CHOLESTEROL REDUCTION, AND IMPROVED GUT HEALTH TO FUEL DEMAND FOR BETA-GLUCAN 131
TABLE 43 DIETARY SUPPLEMENTS: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION) 132
TABLE 44 DIETARY SUPPLEMENTS: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION) 132
8.7 ANIMAL FEED 132
8.7.1 BETA-GLUCAN TO IMPROVE GROWTH AND FEED EFFICIENCY IN LIVESTOCK AND HELP THEM RESIST INFECTIONS AND DISEASES 132
TABLE 45 ANIMAL FEED: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION) 133
TABLE 46 ANIMAL FEED: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION) 133
TABLE 47 ANIMAL FEED: BETA-GLUCAN MARKET, BY SUB-APPLICATION, 2019–2023 (USD MILLION) 133
TABLE 48 ANIMAL FEED: BETA-GLUCAN MARKET, BY SUB-APPLICATION, 2024–2029 (USD MILLION) 133
8.7.1.1 Pets 134
8.7.1.2 Livestock 134
9 BETA-GLUCAN MARKET, BY BRAND 135
9.1 INTRODUCTION 135
9.2 EPICOR 135
9.3 BETAVIA 135
9.4 M-GARD 135
9.5 AVENACARE 135
9.6 AB BIOTEK HUMAN NUTRITION AND HEALTH 136
9.7 YESTIMUN 136
9.8 BENICAROS 136
9.9 IMMUDYNE NUTRITIONAL PUREMUNE 137
9.10 WELLMUNE 137
9.11 OTHER BRANDS 137
9.11.1 OATWELL 137
9.11.2 PROMOAT 137
9.11.3 SANACEL 137
9.11.4 AVENACARE 138
9.11.5 NUTRIM 138
10 BETA-GLUCAN MARKET, BY CATEGORY 139
10.1 INTRODUCTION 140
FIGURE 48 BETA-GLUCAN MARKET, BY CATEGORY, 2024 VS. 2029 (USD MILLION) 140
TABLE 49 BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION) 140
TABLE 50 BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION) 140
10.2 SOLUBLE BETA-GLUCAN 141
10.2.1 SOLUBLE BETA-GLUCAN TO REDUCE CHOLESTEROL LEVELS AND IMPROVE IMMUNE FUNCTION 141
TABLE 51 SOLUBLE: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION) 141
TABLE 52 SOLUBLE: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION) 142
10.3 INSOLUBLE BETA-GLUCAN 142
10.3.1 INSOLUBLE BETA-GLUCAN TO MAINTAIN HEALTHY DIGESTIVE SYSTEM BY FACILITATING SMOOTH MOVEMENT OF FOOD THROUGH DIGESTIVE TRACT 142
TABLE 53 INSOLUBLE: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION) 143
TABLE 54 INSOLUBLE: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION) 143
11 BETA-GLUCAN MARKET, BY SOURCE 144
11.1 INTRODUCTION 145
FIGURE 49 BETA-GLUCAN MARKET, BY SOURCE, 2024 VS. 2029 (USD MILLION) 145
TABLE 55 BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (USD MILLION) 145
TABLE 56 BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (USD MILLION) 146
TABLE 57 BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (TONS) 146
TABLE 58 BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (TONS) 146
11.2 CEREALS & GRAINS 146
11.2.1 NEED FOR REDUCING CHOLESTEROL LEVELS, IMPROVING HEART HEALTH, AND BOOSTING IMMUNE SYSTEM TO DRIVE MARKET 146
TABLE 59 CEREALS & GRAINS: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION) 148
TABLE 60 CEREALS & GRAINS: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION) 148
TABLE 61 CEREALS & GRAINS: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (TONS) 148
TABLE 62 CEREALS & GRAINS: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (TONS) 149
11.3 MUSHROOMS 149
11.3.1 GLUCAN FROM MUSHROOMS TO OFFER IMMUNE HEALTH BENEFITS AND IMPROVE SKIN HEALTH AND ANTI-INFLAMMATORY EFFECTS 149
TABLE 63 MUSHROOMS: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION) 150
TABLE 64 MUSHROOMS: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION) 150
TABLE 65 MUSHROOMS: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (TONS) 150
TABLE 66 MUSHROOMS: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (TONS) 151
11.4 YEAST 151
11.4.1 RISING PREVALENCE OF CHRONIC DISEASES, GROWING AWARENESS ABOUT HEALTH BENEFITS OF BETA-GLUCAN, AND SUPPORT OF GOVERNMENTS FOR RESEARCH AND DEVELOPMENT TO FOSTER MARKET 151
TABLE 67 YEAST: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION) 152
TABLE 68 YEAST: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION) 152
TABLE 69 YEAST: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (TONS) 152
TABLE 70 YEAST: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (TONS) 153
11.5 SEAWEED 153
11.5.1 SEAWEED-BASED BETA-GLUCAN TO BE USED IN COSMETIC AND PERSONAL CARE PRODUCTS FOR ITS MOISTURIZING, ANTI-INFLAMMATORY, AND ANTIOXIDANT PROPERTIES 153
TABLE 71 SEAWEED: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION) 154
TABLE 72 SEAWEED: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION) 154
TABLE 73 SEAWEED: BETA-GLUCAN MARKET, 2019–2023 (TONS) 154
TABLE 74 SEAWEED: BETA-GLUCAN MARKET, 2024–2029 (TONS) 155
12 BETA-GLUCAN MARKET, BY TYPE 156
12.1 INTRODUCTION 157
FIGURE 50 BETA-GLUCAN MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 157
TABLE 75 BETA-GLUCAN MARKET, BY TYPE, 2019–2023 (USD MILLION) 157
TABLE 76 BETA-GLUCAN MARKET, BY TYPE, 2024–2029 (USD MILLION) 157
12.2 1,3 BETA-GLUCAN 158
12.2.1 1,3 BETA-GLUCAN TO ENHANCE IMMUNE FUNCTION BY ACTIVATING VARIOUS IMMUNE CELLS AND IMPROVE SKIN HEALTH 158
TABLE 77 1,3 BETA-GLUCAN: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION) 158
TABLE 78 1,3 BETA-GLUCAN: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION) 159
12.3 1,4 BETA-GLUCAN 159
12.3.1 OAT AND BARLEY-DERIVED 1,4 BETA-GLUCAN TO LOWER CHOLESTEROL AND ENHANCE CARDIOVASCULAR HEALTH 159
TABLE 79 1,4 BETA-GLUCAN: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION) 159
TABLE 80 1,4 BETA-GLUCAN: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION) 160
12.4 1,6 BETA-GLUCAN 160
12.4.1 DEMAND FOR 1,6 BETA-GLUCAN TO RISE DUE TO ITS IMMUNE-BOOSTING AND SKIN HEALTH BENEFITS 160
TABLE 81 1,6 BETA-GLUCAN: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION) 160
TABLE 82 1,6 BETA-GLUCAN: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION) 161
13 BETA-GLUCAN MARKET, BY REGION 162
13.1 INTRODUCTION 163
FIGURE 51 ASIA PACIFIC COUNTRIES TO WITNESS SIGNIFICANT GROWTH IN BETA-GLUCAN MARKET, 2024–2029 163
TABLE 83 BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION) 164
TABLE 84 BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION) 164
TABLE 85 BETA-GLUCAN MARKET, BY REGION, 2019–2023 (TONS) 164
TABLE 86 BETA-GLUCAN MARKET, BY REGION, 2024–2029 (TONS) 165
13.2 NORTH AMERICA 165
FIGURE 52 NORTH AMERICA: BETA-GLUCAN MARKET SNAPSHOT 166
13.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS 166
FIGURE 53 NORTH AMERICA: COUNTRY-LEVEL DATA OF INFLATION, 2017–2022 167
FIGURE 54 NORTH AMERICAN BETA-GLUCAN MARKET: RECESSION IMPACT ANALYSIS 167
TABLE 87 NORTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2019–2023 (USD MILLION) 168
TABLE 88 NORTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 168
TABLE 89 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (USD MILLION) 168
TABLE 90 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (USD MILLION) 168
TABLE 91 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (TONS) 169
TABLE 92 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (TONS) 169
TABLE 93 NORTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION) 169
TABLE 94 NORTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION) 169
TABLE 95 NORTH AMERICA: BETA-GLUCAN MARKET, BY TYPE, 2019–2023 (USD MILLION) 170
TABLE 96 NORTH AMERICA: BETA-GLUCAN MARKET, BY TYPE, 2024–2029 (USD MILLION) 170
TABLE 97 NORTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 170
TABLE 98 NORTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 171
TABLE 99 NORTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2019–2023 (USD MILLION) 171
TABLE 100 NORTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2024–2029 (USD MILLION) 171
TABLE 101 NORTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION) 172
TABLE 102 NORTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION) 172
TABLE 103 NORTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2019–2023 (USD MILLION) 172
TABLE 104 NORTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2024–2029 (USD MILLION) 173
TABLE 105 NORTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION) 173
TABLE 106 NORTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION) 173
TABLE 107 NORTH AMERICA: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2019–2023 (USD MILLION) 174
TABLE 108 NORTH AMERICA: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2024–2029 (USD MILLION) 174
13.2.2 US 174
13.2.2.1 Increasing number of product launches by food manufacturers to fuel demand for beta-glucan 174
TABLE 109 US: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION) 175
TABLE 110 US: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION) 175
TABLE 111 US: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 175
TABLE 112 US: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 176
13.2.3 CANADA 176
13.2.3.1 Government approvals and rising efforts from market players to accelerate market growth 176
TABLE 113 CANADA: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION) 177
TABLE 114 CANADA: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION) 177
TABLE 115 CANADA: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 177
TABLE 116 CANADA: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 178
13.2.4 MEXICO 178
13.2.4.1 Rise in chronic lifestyle diseases, demand for health-benefiting products, and government initiatives to promote healthy lifestyles to drive market 178
TABLE 117 MEXICO: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION) 178
TABLE 118 MEXICO: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION) 179
TABLE 119 MEXICO: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 179
TABLE 120 MEXICO: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 179
13.3 EUROPE 180
13.3.1 EUROPE: RECESSION IMPACT ANALYSIS 180
FIGURE 55 EUROPE: COUNTRY-LEVEL DATA FOR INFLATION, 2017–2022 181
FIGURE 56 EUROPEAN BETA-GLUCAN MARKET: RECESSION IMPACT ANALYSIS 182
TABLE 121 EUROPE: BETA-GLUCAN MARKET, BY COUNTRY, 2019–2023 (USD MILLION) 182
TABLE 122 EUROPE: BETA-GLUCAN MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 182
TABLE 123 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (USD MILLION) 183
TABLE 124 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (USD MILLION) 183
TABLE 125 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (TONS) 183
TABLE 126 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (TONS) 184
TABLE 127 EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION) 184
TABLE 128 EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION) 184
TABLE 129 EUROPE: BETA-GLUCAN MARKET, BY TYPE, 2019–2023 (USD MILLION) 184
TABLE 130 EUROPE: BETA-GLUCAN MARKET, BY TYPE, 2024–2029 (USD MILLION) 185
TABLE 131 EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 185
TABLE 132 EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 185
TABLE 133 EUROPE: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2019–2023 (USD MILLION) 186
TABLE 134 EUROPE: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2024–2029 (USD MILLION) 186
TABLE 135 EUROPE: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION) 186
TABLE 136 EUROPE: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION) 187
TABLE 137 EUROPE: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2019–2023 (USD MILLION) 187
TABLE 138 EUROPE: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2024–2029 (USD MILLION) 187
TABLE 139 EUROPE: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION) 188
TABLE 140 EUROPE: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION) 188
TABLE 141 EUROPE: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2019–2023 (USD MILLION) 188
TABLE 142 EUROPE: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2024–2029 (USD MILLION) 189
13.3.2 GERMANY 189
13.3.2.1 Inclination toward natural and organic foods and rising prevalence of health-related problems to propel market 189
TABLE 143 GERMANY: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION) 189
TABLE 144 GERMANY: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION) 190
TABLE 145 GERMANY: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 190
TABLE 146 GERMANY: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 190
13.3.3 FRANCE 191
13.3.3.1 Rising incidence of lifestyle diseases, growing demand for functional foods, and favorable government policies to drive market 191
TABLE 147 FRANCE: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION) 191
TABLE 148 FRANCE: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION) 191
TABLE 149 FRANCE: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 192
TABLE 150 FRANCE: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 192
13.3.4 UK 192
13.3.4.1 Rising demand for healthier and more sustainable products and government’s focus on awareness programs to promote healthy diet to drive market 192
TABLE 151 UK: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION) 193
TABLE 152 UK: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION) 193
TABLE 153 UK: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 193
TABLE 154 UK: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 194
13.3.5 ITALY 194
13.3.5.1 Rising demand for health-enriching ingredients to prevent risk of chronic diseases to foster market growth 194
TABLE 155 ITALY: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION) 194
TABLE 156 ITALY: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION) 195
TABLE 157 ITALY: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 195
TABLE 158 ITALY: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 195
13.3.6 SPAIN 196
13.3.6.1 Rising export opportunities and need to optimize animal health to boost demand for beta-glucan 196
TABLE 159 SPAIN: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION) 196
TABLE 160 SPAIN: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION) 196
TABLE 161 SPAIN: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 197
TABLE 162 SPAIN: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 197
13.3.7 REST OF EUROPE 197
TABLE 163 REST OF EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION) 198
TABLE 164 REST OF EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION) 198
TABLE 165 REST OF EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 198
TABLE 166 REST OF EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 199
13.4 ASIA PACIFIC 199
FIGURE 57 ASIA PACIFIC: BETA-GLUCAN MARKET SNAPSHOT 200
13.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS 200
FIGURE 58 ASIA PACIFIC: KEY COUNTRY-WISE INFLATION RATES, 2017–2022 201
FIGURE 59 ASIA PACIFIC: RECESSION IMPACT ANALYSIS, 2023 201
TABLE 167 ASIA PACIFIC: BETA-GLUCAN MARKET, BY COUNTRY, 2019–2023 (USD MILLION) 202
TABLE 168 ASIA PACIFIC: BETA-GLUCAN MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 202
TABLE 169 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (USD MILLION) 202
TABLE 170 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (USD MILLION) 203
TABLE 171 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (TONS) 203
TABLE 172 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (TONS) 203
TABLE 173 ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION) 203
TABLE 174 ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION) 204
TABLE 175 ASIA PACIFIC: BETA-GLUCAN MARKET, BY TYPE, 2019–2023 (USD MILLION) 204
TABLE 176 ASIA PACIFIC: BETA-GLUCAN MARKET, BY TYPE, 2024–2029 (USD MILLION) 204
TABLE 177 ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 204
TABLE 178 ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 205
TABLE 179 ASIA PACIFIC: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2019–2023 (USD MILLION) 205
TABLE 180 ASIA PACIFIC: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2024–2029 (USD MILLION) 205
TABLE 181 ASIA PACIFIC: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION) 206
TABLE 182 ASIA PACIFIC: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION) 206
TABLE 183 ASIA PACIFIC: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2019–2023 (USD MILLION) 206
TABLE 184 ASIA PACIFIC: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2024–2029 (USD MILLION) 207
TABLE 185 ASIA PACIFIC: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION) 207
TABLE 186 ASIA PACIFIC: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION) 207
TABLE 187 ASIA PACIFIC: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2019–2023 (USD MILLION) 208
TABLE 188 ASIA PACIFIC: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2024–2029 (USD MILLION) 208
13.4.2 CHINA 208
13.4.2.1 Higher demand for high-quality processed foods and presence of major vendors to foster market growth 208
TABLE 189 CHINA: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION) 209
TABLE 190 CHINA: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION) 209
TABLE 191 CHINA: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 209
TABLE 192 CHINA: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 210
13.4.3 JAPAN 210
13.4.3.1 Rise in healthcare costs and higher life expectancy due to preventive healthcare measures to drive market 210
TABLE 193 JAPAN: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION) 211
TABLE 194 JAPAN: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION) 211
TABLE 195 JAPAN: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 211
TABLE 196 JAPAN: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 212
13.4.4 INDIA 212
13.4.4.1 Promotion of innovation and product development in food industry to fuel demand for beta-glucan 212
TABLE 197 INDIA: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION) 213
TABLE 198 INDIA: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION) 213
TABLE 199 INDIA: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 213
TABLE 200 INDIA: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 214
13.4.5 AUSTRALIA & NEW ZEALAND 214
13.4.5.1 Need to promote animal growth, boost immunity, and improve overall productivity to propel market 214
TABLE 201 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION) 215
TABLE 202 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION) 215
TABLE 203 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 215
TABLE 204 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 216
13.4.6 REST OF ASIA PACIFIC 216
TABLE 205 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION) 217
TABLE 206 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION) 217
TABLE 207 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 217
TABLE 208 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 218
13.5 SOUTH AMERICA 218
13.5.1 SOUTH AMERICA: RECESSION IMPACT ANALYSIS 218
FIGURE 60 SOUTH AMERICA: COUNTRY-LEVEL DATA FOR INFLATION, 2017–2022 219
FIGURE 61 SOUTH AMERICA BETA-GLUCAN MARKET: RECESSION IMPACT ANALYSIS 220
TABLE 209 SOUTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2019–2023 (USD MILLION) 220
TABLE 210 SOUTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 220
TABLE 211 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (USD MILLION) 221
TABLE 212 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (USD MILLION) 221
TABLE 213 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (TONS) 221
TABLE 214 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (TONS) 222
TABLE 215 SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION) 222
TABLE 216 SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION) 222
TABLE 217 SOUTH AMERICA: BETA-GLUCAN MARKET, BY TYPE, 2019–2023 (USD MILLION) 222
TABLE 218 SOUTH AMERICA: BETA-GLUCAN MARKET, BY TYPE, 2024–2029 (USD MILLION) 223
TABLE 219 SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 223
TABLE 220 SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 223
TABLE 221 SOUTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2019–2023 (USD MILLION) 224
TABLE 222 SOUTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2024–2029 (USD MILLION) 224
TABLE 223 SOUTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION) 224
TABLE 224 SOUTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION) 225
TABLE 225 SOUTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2019–2023 (USD MILLION) 225
TABLE 226 SOUTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2024–2029 (USD MILLION) 225
TABLE 227 SOUTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION) 226
TABLE 228 SOUTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION) 226
TABLE 229 SOUTH AMERICA: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2019–2023 (USD MILLION) 226
TABLE 230 SOUTH AMERICA: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2024–2029 (USD MILLION) 227
13.5.2 BRAZIL 227
13.5.2.1 Rising geriatric population, surge in obesity levels, urbanization, and health consciousness to spur market growth 227
TABLE 231 BRAZIL: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION) 227
TABLE 232 BRAZIL: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION) 228
TABLE 233 BRAZIL: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 228
TABLE 234 BRAZIL: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 228
13.5.3 ARGENTINA 229
13.5.3.1 Need for reducing cholesterol levels and promoting digestion to fuel demand for oats-derived beta-glucan 229
TABLE 235 ARGENTINA: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION) 229
TABLE 236 ARGENTINA: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION) 229
TABLE 237 ARGENTINA: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 230
TABLE 238 ARGENTINA: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 230
13.5.4 REST OF SOUTH AMERICA 230
TABLE 239 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION) 231
TABLE 240 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION) 231
TABLE 241 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 232
TABLE 242 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 232
13.6 REST OF THE WORLD (ROW) 232
13.6.1 ROW: RECESSION IMPACT ANALYSIS 232
FIGURE 62 ROW: KEY COUNTRY-WISE INFLATION RATES, 2017–2022 233
FIGURE 63 ROW: RECESSION IMPACT ANALYSIS, 2023 233
TABLE 243 ROW: BETA-GLUCAN MARKET, BY COUNTRY, 2019–2023 (USD MILLION) 234
TABLE 244 ROW: BETA-GLUCAN MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 234
TABLE 245 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (USD MILLION) 234
TABLE 246 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (USD MILLION) 234
TABLE 247 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (TONS) 235
TABLE 248 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (TONS) 235
TABLE 249 ROW: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION) 235
TABLE 250 ROW: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION) 235
TABLE 251 ROW: BETA-GLUCAN MARKET, BY TYPE, 2019–2023 (USD MILLION) 236
TABLE 252 ROW: BETA-GLUCAN MARKET, BY TYPE, 2024–2029 (USD MILLION) 236
TABLE 253 ROW: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 236
TABLE 254 ROW: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 237
TABLE 255 ROW: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2019–2023 (USD MILLION) 237
TABLE 256 ROW: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2024–2029 (USD MILLION) 237
TABLE 257 ROW: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION) 238
TABLE 258 ROW: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION) 238
TABLE 259 ROW: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2019–2023 (USD MILLION) 238
TABLE 260 ROW: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2024–2029 (USD MILLION) 239
TABLE 261 ROW: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION) 239
TABLE 262 ROW: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION) 239
TABLE 263 ROW: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2019–2023 (USD MILLION) 240
TABLE 264 ROW: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2024–2029 (USD MILLION) 240
13.6.2 MIDDLE EAST 240
13.6.2.1 Expanding middle-class population and industrial growth and increased health and wellness initiatives in Middle East to drive market 240
TABLE 265 MIDDLE EAST: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION) 241
TABLE 266 MIDDLE EAST: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION) 241
TABLE 267 MIDDLE EAST: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 241
TABLE 268 MIDDLE EAST: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 242
13.6.3 AFRICA 242
13.6.3.1 Growing demand for natural and functional ingredients to boost demand for beta-glucan ingredients 242
TABLE 269 AFRICA: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION) 243
TABLE 270 AFRICA: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION) 243
TABLE 271 AFRICA: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION) 243
TABLE 272 AFRICA: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 244
14 COMPETITIVE LANDSCAPE 245
14.1 OVERVIEW 245
14.2 REVENUE ANALYSIS 245
FIGURE 64 SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS, 2019–2023 (USD BILLION) 245
14.3 MARKET SHARE ANALYSIS 246
TABLE 273 BETA-GLUCAN MARKET: MARKET SHARE ANALYSIS, 2023 246
14.4 KEY PLAYER STRATEGIES/RIGHT TO WIN 247
TABLE 274 OVERVIEW OF STRATEGIES ADOPTED BY KEY BETA-GLUCAN PLAYERS 247
14.5 COMPANY VALUATION AND FINANCIAL METRICS 249
FIGURE 65 COMPANY VALUATION 249
FIGURE 66 EV/EBITDA OF FEW MAJOR PLAYERS 250
14.6 BRAND/PRODUCT COMPARISON ANALYSIS 250
FIGURE 67 BETA-GLUCAN MARKET: BRAND/PRODUCT COMPARISON ANALYSIS 250
14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 251
14.7.1 STARS 251
14.7.2 EMERGING LEADERS 251
14.7.3 PERVASIVE PLAYERS 251
14.7.4 PARTICIPANTS 251
FIGURE 68 BETA-GLUCAN MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2023 252
14.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 253
14.7.5.1 Company footprint 253
FIGURE 69 OVERALL COMPANY FOOTPRINT 253
14.7.5.2 Regional footprint 254
TABLE 275 REGIONAL FOOTPRINT 254
14.7.5.3 Source footprint 255
TABLE 276 SOURCE FOOTPRINT 255
14.7.5.4 Application footprint 256
TABLE 277 APPLICATION FOOTPRINT 256
14.7.5.5 Type footprint 257
TABLE 278 TYPE FOOTPRINT 257
14.8 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023 257
14.8.1 PROGRESSIVE COMPANIES 257
14.8.2 RESPONSIVE COMPANIES 257
14.8.3 DYNAMIC COMPANIES 258
14.8.4 STARTING BLOCKS 258
FIGURE 70 BETA-GLUCAN MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2023 258
14.8.5 COMPETITIVE BENCHMARKING, START-UPS/SMES, 2023 259
14.8.5.1 Detailed list of key start-ups/SMEs 259
TABLE 279 BETA-GLUCAN MARKET: LIST OF KEY START-UPS/SMES 259
14.8.5.2 Competitive benchmarking of key start-ups/SMEs 260
TABLE 280 BETA-GLUCAN MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES 260
14.9 COMPETITIVE SCENARIO AND TRENDS 261
14.9.1 DEALS 261
TABLE 281 BETA-GLUCAN MARKET: DEALS, 2020–2022 261
14.9.2 EXPANSIONS 262
TABLE 282 BETA-GLUCAN MARKET: EXPANSIONS, 2019–2022 262
15 COMPANY PROFILES 264
(Business Overview, Products/Solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
15.1 KEY PLAYERS 264
15.1.1 TATE & LYLE PLC 264
TABLE 283 TATE & LYLE PLC: BUSINESS OVERVIEW 264
FIGURE 71 TATE & LYLE PLC: COMPANY SNAPSHOT 265
TABLE 284 TATE & LYLE PLC: INGREDIENTS OFFERED 265
TABLE 285 TATE & LYLE PLC: DEALS 266
TABLE 286 TATE & LYLE PLC: EXPANSIONS 266
TABLE 287 TATE & LYLE PLC: OTHER DEVELOPMENTS 267
15.1.2 KERRY GROUP PLC 268
TABLE 288 KERRY GROUP PLC: BUSINESS OVERVIEW 268
FIGURE 72 KERRY GROUP PLC: COMPANY SNAPSHOT 269
TABLE 289 KERRY GROUP PLC: INGREDIENTS OFFERED 269
15.1.3 DSM-FIRMENICH 271
TABLE 290 DSM-FIRMENICH: BUSINESS OVERVIEW 271
FIGURE 73 DSM-FIRMENICH: COMPANY SNAPSHOT 272
TABLE 291 DSM-FIRMENICH: INGREDIENTS OFFERED 272
TABLE 292 DSM-FIRMENICH: EXPANSIONS 273
15.1.4 ANGEL YEAST CO., LTD. 274
TABLE 293 ANGEL YEAST CO., LTD.: BUSINESS OVERVIEW 274
FIGURE 74 ANGEL YEAST CO., LTD: COMPANY SNAPSHOT 275
TABLE 294 ANGEL YEAST CO., LTD.: INGREDIENTS OFFERED 275
TABLE 295 ANGEL YEAST CO., LTD.: PRODUCTS OFFERED 276
TABLE 296 ANGEL YEAST CO., LTD.: EXPANSIONS 276
15.1.5 MERCK 278
TABLE 297 MERCK: BUSINESS OVERVIEW 278
FIGURE 75 MERCK: COMPANY SNAPSHOT 279
TABLE 298 MERCK: INGREDIENTS OFFERED 279
TABLE 299 MERCK: EXPANSIONS 280
15.1.6 ASSOCIATED BRITISH FOODS PLC 282
TABLE 300 ASSOCIATED BRITISH FOODS PLC: BUSINESS OVERVIEW 282
FIGURE 76 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT 283
TABLE 301 ASSOCIATED BRITISH FOODS PLC: INGREDIENTS OFFERED 283
TABLE 302 ASSOCIATED BRITISH FOODS PLC: PRODUCTS OFFERED 284
15.1.7 CEAPRO INC. 285
TABLE 303 CEAPRO INC.: BUSINESS OVERVIEW 285
FIGURE 77 CEAPRO INC.: COMPANY SNAPSHOT 286
TABLE 304 CEAPRO INC.: INGREDIENTS OFFERED 286
TABLE 305 CEAPRO INC.: DEALS 287
TABLE 306 CEAPRO INC.: OTHER DEVELOPMENTS 287
15.1.8 LESAFFRE 289
TABLE 307 LESAFFRE: BUSINESS OVERVIEW 289
TABLE 308 LESAFFRE: INGREDIENTS OFFERED 290
TABLE 309 LESAFFRE: PRODUCTS OFFERED 290
TABLE 310 LESAFFRE: DEALS 290
15.1.9 KEMIN INDUSTRIES, INC. 292
TABLE 311 KEMIN INDUSTRIES, INC.: BUSINESS OVERVIEW 292
TABLE 312 KEMIN INDUSTRIES, INC.: INGREDIENTS OFFERED 292
TABLE 313 KEMIN INDUSTRIES, INC.: EXPANSIONS 293
TABLE 314 KEMIN INDUSTRIES, INC.: OTHER DEVELOPMENTS 293
15.1.10 FOODCHEM INTERNATIONAL CORPORATION 294
TABLE 315 FOODCHEM INTERNATIONAL CORPORATION: BUSINESS OVERVIEW 294
TABLE 316 FOODCHEM INTERNATIONAL CORPORATION: INGREDIENTS OFFERED 294
15.1.11 LALLEMAND 295
TABLE 317 LALLEMAND: BUSINESS OVERVIEW 295
TABLE 318 LALLEMAND: INGREDIENTS OFFERED 295
TABLE 319 LALLEMAND: PRODUCTS OFFERED 296
TABLE 320 LALLEMAND: DEALS 296
15.1.12 BIORIGIN 297
TABLE 321 BIORIGIN: BUSINESS OVERVIEW 297
TABLE 322 BIORIGIN: INGREDIENTS OFFERED 297
15.1.13 NUTRISCIENCE INNOVATIONS, LLC 298
TABLE 323 NUTRISCIENCE INNOVATIONS, LLC: BUSINESS OVERVIEW 298
TABLE 324 NUTRISCIENCE INNOVATIONS, LLC: INGREDIENTS OFFERED 298
15.1.14 LEIBER 299
TABLE 325 LEIBER: BUSINESS OVERVIEW 299
TABLE 326 LEIBER: INGREDIENTS OFFERED 299
TABLE 327 LEIBER: PRODUCTS OFFERED 300
15.1.15 GARUDA INTERNATIONAL INC. 301
TABLE 328 GARUDA INTERNATIONAL INC.: BUSINESS OVERVIEW 301
TABLE 329 GARUDA INTERNATIONAL INC.: INGREDIENTS OFFERED 301
15.2 OTHER PLAYERS 303
15.2.1 VW-INGREDIENTS 303
TABLE 330 VW-INGREDIENTS: BUSINESS OVERVIEW 303
TABLE 331 VW-INGREDIENTS: INGREDIENTS OFFERED 303
15.2.2 SUPER BETA GLUCAN 305
TABLE 332 SUPER BETA GLUCAN: BUSINESS OVERVIEW 305
TABLE 333 SUPER BETA GLUCAN: INGREDIENTS OFFERED 305
15.2.3 GLYCANOVA AS 306
TABLE 334 GLYCANOVA AS: BUSINESS OVERVIEW 306
TABLE 335 GLYCANOVA AS: INGREDIENTS OFFERED 306
TABLE 336 GLYCANOVA AS: PRODUCTS OFFERED 307
15.2.4 SPECIALTY BIOTECH CO., LTD. 308
TABLE 337 SPECIALTY BIOTECH CO., LTD.: BUSINESS OVERVIEW 308
TABLE 338 SPECIALTY BIOTECH CO., LTD.: INGREDIENTS OFFERED 308
15.2.5 ALGALÍF ICELAND HF. 310
TABLE 339 ALGALÍF ICELAND HF.: BUSINESS OVERVIEW 310
TABLE 340 ALGALÍF ICELAND HF.: INGREDIENTS OFFERED 310
15.2.6 NATURAL BIOLOGICS 311
TABLE 341 NATURAL BIOLOGICS: BUSINESS OVERVIEW 311
15.2.7 ABAC R&D AG 311
TABLE 342 ABAC R&D AG: BUSINESS OVERVIEW 311
15.2.8 BENEO 312
TABLE 343 BENEO: BUSINESS OVERVIEW 312
15.2.9 L&P FOOD INGREDIENT CO., LTD 313
TABLE 344 L&P FOOD INGREDIENT CO., LTD: BUSINESS OVERVIEW 313
15.2.10 BETA BIO TECHNOLOGY SP. Z O. O. 313
TABLE 345 BETA BIO TECHNOLOGY SP. Z O. O. : BUSINESS OVERVIEW 313
15.3 PRODUCT-BASED COMPANIES 314
15.3.1 CARGILL, INCORPORATED 314
TABLE 346 CARGILL, INCORPORATED: BUSINESS OVERVIEW 314
15.3.2 INTERNATIONAL FLAVORS & FRAGRANCES, INC. 315
TABLE 347 INTERNATIONAL FLAVORS & FRAGRANCES, INC.: BUSINESS OVERVIEW 315
15.3.3 VIVESA HOLDING S.R.O 316
TABLE 348 VIVESA HOLDING S.R.O: BUSINESS OVERVIEW 316
15.3.4 ALERIS 317
TABLE 349 ALERIS: BUSINESS OVERVIEW 317
15.3.5 ICC 318
TABLE 350 ICC: BUSINESS OVERVIEW 318
15.3.6 PROSOL S.P.A. 319
TABLE 351 PROSOL S.P.A.: BUSINESS OVERVIEW 319
15.3.7 ABN APLICACIONES BIOLÓGICAS A LA NUTRICIÓN 320
TABLE 352 ABN APLICACIONES BIOLÓGICAS A LA NUTRICIÓN: BUSINESS OVERVIEW 320
15.3.8 EW NUTRITION 321
TABLE 353 EW NUTRITION: BUSINESS OVERVIEW 321
15.3.9 BIOCHEM ZUSATZSTOFFE HANDELS- UND PRODUKTIONSGESELLSCHAFT MBH 322
TABLE 354 BIOCHEM ZUSATZSTOFFE HANDELS- UND PRODUKTIONSGESELLSCHAFT MBH: BUSINESS OVERVIEW 322
15.3.10 MIBELLE BIOCHEMISTRY 323
TABLE 355 MIBELLE BIOCHEMISTRY: BUSINESS OVERVIEW 323
*Details on Business Overview, Products/Solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
16 ADJACENT & RELATED MARKETS 324
16.1 INTRODUCTION 324
TABLE 356 ADJACENT MARKETS 324
16.2 STUDY LIMITATIONS 324
16.3 YEAST MARKET 324
16.3.1 MARKET DEFINITION 324
16.3.2 MARKET OVERVIEW 325
TABLE 357 YEAST MARKET, BY TYPE, 2019–2023 (USD MILLION) 325
TABLE 358 YEAST MARKET, BY TYPE, 2024–2029 (USD MILLION) 326
16.4 STARTER CULTURE MARKET 326
16.4.1 MARKET DEFINITION 326
16.4.2 MARKET OVERVIEW 326
TABLE 359 STARTER CULTURE MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 327
TABLE 360 STARTER CULTURE MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 327
17 APPENDIX 328
17.1 DISCUSSION GUIDE 328
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 334
17.3 CUSTOMIZATION OPTIONS 336
17.4 RELATED REPORTS 336
17.5 AUTHOR DETAILS 337